Table 4 Cost analysis of public sector
SoC: Tamsulosin monotherapy | Total budget impact (%) | |||||
|---|---|---|---|---|---|---|
Year | Consultation costs (€) | Surgery costs (€) | AUR costs (€) | Drug costs (€) | Total costs (€) | |
1 | 11,497,557 | 8,628,675 | 44,144 | 47,577,203 | 67,747,579 | - |
2 | 11,527,061 | 15,104,305 | 48,573 | 47,785,803 | 74,465,743 | - |
3 | 11,260,338 | 11,638,737 | 45,344 | 47,734,616 | 70,679,036 | - |
4 | 11,412,776 | 13,858,461 | 54,803 | 47,798,059 | 73,124,100 | - |
Tamsulosin monotherapy & gradual introduction of DUT + TAM FDC | ||||||
1 | 11,492,585 | 8,577,613 | 43,687 | 48,930,196 | 69,044,082 | - |
2 | 11,404,330 | 14,669,865 | 47,289 | 50,606,379 | 76,727,862 | - |
3 | 11,102,755 | 11,128,827 | 43,506 | 52,334,084 | 74,609,173 | - |
4 | 11,173,679 | 12,730,920 | 50,963 | 54,976,669 | 78,932,231 | - |
Budget impact | ||||||
1 | -4,972 | -51,061 | -457 | 1,352,994 | 1,296,503 | 1.91 |
2 | -122,731 | -434,440 | -1,284 | 2,820,575 | 2,262,120 | 3.04 |
3 | -157,583 | -509,909 | -1,838 | 4,599,467 | 3,930,137 | 5.56 |
4 | -239,097 | -1,127,541 | -3,840 | 7,178,610 | 5,808,131 | 7.94 |